FDA DEVICE FACTS
Equinoxe® Humeral Reconstruction Prosthesis; Equinoxe® Stemless Shoulder Implants
Exactech, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Equinoxe® Humeral Reconstruction Prosthesis System is intended for use in hemi or total shoulder arthroplasty where proximal humeral resection is deemed necessary in cases of:
• Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis
• Rheumatoid arthritis
• Revision where other devices or treatments have failed
• Correction of functional deformity
• Treatment of acute or chronic fracture with humeral head involvement, which are unmanageable using other treatment
• Traumatic arthritis
• Oncology applications including bone loss due to tumor resection.
• Significant humeral resection which are unmanageable using other treatment methods The Equinoxe® Humeral Reconstruction Prosthesis System can be used in either primary or revision arthroplasty procedures. The Equinoxe® Humeral Reconstruction Prosthesis System is indicated for proximal humeral replacement in conjunction with reverse shoulder arthroplasty in which significant resection of the proximal humerus is necessary, the rotator cuff is irreplaceable and grossly deficient, and a functional deltoid muscle is present. In the USA, the Equinoxe® Humeral Reconstruction Prosthesis System is not indicated for use with the Equinoxe Reverse Shoulder System components in oncology applications. The Equinoxe® Humeral Reconstruction Prosthesis Distal Stems are for cemented use only, while the HA coated Equinoxe® Humeral Reconstruction Prosthesis Distal Stem Collars are only for uncemented, press fit use. Stemless Shoulder The Equinoxe® Stemless Shoulder System is indicated for use in skeletally mature individuals with degenerative diseases of the glenohumeral joint where anatomic total shoulder arthroplasty is determined by the surgeon to be the preferred method of treatment. Clinical indications for anatomic total shoulder arthroplasty are as follows:
• Osteoarthritis, osteonecrosis or post-traumatic degenerative problems.
• Congenital abnormalities in the skeletally mature.
• Primary and secondary necrosis of the humeral head.
• Pathologies where arthrodesis or resectional arthroplasty of the humeral head are not acceptable.
• Revisions of humeral prostheses when other treatments or devices have failed (where adequate fixation can be achieved).
• To restore mobility from previous procedures (e.g. previous fusion). The Equinoxe® Stemless Shoulder humeral components are indicated for press-fit, uncemented use. The Equinoxe® Stemless Shoulder System is intended to be used with the cemented Equinoxe® glenoid components.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。